-92%
Comprehensive Hematology Certification Preparation and Continuing Education
Understanding the Course Highlights and Scope
Comprehensive Content:
This course offers a comprehensive review of hematology, covering essential topics outlined in the hematology ABIM Blueprint. With up to 44.50 hours of exam-focused content, it provides an in-depth preparation for board certification exams or for professionals seeking an extensive update on hematology best practices.
Expert Faculty and Accessible Delivery:
The course features engaging video presentations delivered by renowned clinician-educators. Access to content is seamless, allowing learners to access materials from any computer, mobile device, or smartphone.
Practice and Assessment Tools:
A practice exam with challenging questions equips learners with firsthand experience in exam preparation. The course also includes access to the electronic syllabus for easy reference and CME credits and MOC points for professional development.
Target Audience and Learning Objectives
This course is tailored for physicians preparing for the Hematology and Medical Oncology certification exams, as well as individuals seeking a thorough review of hematology and medical oncology standards of care.
Upon completing the course, learners will:
Hematopathology:
- Comprehend red cell disorders, including their diagnosis and management
- Stay abreast of established and emerging clinical advances in coagulopathies, anticoagulant therapies, and thrombolytic therapies
- Gain a strong understanding of blood and marrow morphology and hematopathology
- Explore recent clinical advancements in immunohematology, bone marrow transplantation, and hematopoietic growth factors
Hematologic Malignancies:
- Develop proficiency in diagnosing, evaluating, and managing hematologic malignancies
- Familiarize themselves with the latest pharmacology and toxicology of anti-neoplastic drugs
- Acquire effective strategies for maximizing success on board examinations
Course Structure and Timeline
Hematology:
- Session 1: Anemias, Bone Marrow Failure, and Sickle Cell Disease
- Session 2: WBC Disorders and Coagulopathy
- Session 3: Thrombocytopenias, Anemias, and Myeloproliferative Disease
Hematologic Malignancies:
- Session 1: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS
- Session 2: AML, Pharmacology, and BMT
The course commences on August 12, 2020, and concludes on December 31, 2021, providing ample time for learners to engage with the content and achieve their educational goals.
Reviews
Clear filtersThere are no reviews yet.